Cargando…

Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection()

BACKGROUND AND OBJECTIVE: Olfactory and taste dysfunction (OD, TD) have been considered symptoms of SARS-CoV-2 infection. However, its presence in certain populations, especially those with mild clinical symptoms, has not been clarified. The objective was to estimate the frequency of OD and TD, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérula de Torres, Luis Ángel, González-Lama, Jesús, Jiménez García, Celia, Sánchez Montero, Rosa, Rider Garrido, Faustino, Ortega López, Yolanda, Pajares Conde, Diego, Ramírez Baena, Miguel, Párraga Martínez, Ignacio, Romero-Rodríguez, Esperanza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141902/
https://www.ncbi.nlm.nih.gov/pubmed/34056110
http://dx.doi.org/10.1016/j.medcle.2020.12.024
_version_ 1783696465093197824
author Pérula de Torres, Luis Ángel
González-Lama, Jesús
Jiménez García, Celia
Sánchez Montero, Rosa
Rider Garrido, Faustino
Ortega López, Yolanda
Pajares Conde, Diego
Ramírez Baena, Miguel
Párraga Martínez, Ignacio
Romero-Rodríguez, Esperanza
author_facet Pérula de Torres, Luis Ángel
González-Lama, Jesús
Jiménez García, Celia
Sánchez Montero, Rosa
Rider Garrido, Faustino
Ortega López, Yolanda
Pajares Conde, Diego
Ramírez Baena, Miguel
Párraga Martínez, Ignacio
Romero-Rodríguez, Esperanza
author_sort Pérula de Torres, Luis Ángel
collection PubMed
description BACKGROUND AND OBJECTIVE: Olfactory and taste dysfunction (OD, TD) have been considered symptoms of SARS-CoV-2 infection. However, its presence in certain populations, especially those with mild clinical symptoms, has not been clarified. The objective was to estimate the frequency of OD and TD, and its predictive validity in patients detected in Primary Care. PATIENTS AND METHODS: A cross-sectional study was carried out in the Spanish National Health System. An epidemiological survey was administered to patients who were requested the PCR test for SARS-CoV-2. Odds ratio (OR) were estimated to measure the magnitude of the association between OD and TD and the existence of SARS-CoV-2 infection. The sensitivity, specificity, and positive and negative predictive values (PPV, NPV) of these symptoms in SARS-CoV-2 infection were calculated. RESULTS: Of 1038 patients screened, 20.1% had SARS-CoV-2 infection. OD and DG were present in 64.4% (95% CI 56.0–72.1) and 56.2% (95% CI 47.9–64.2) of the subjects with infection, respectively. The OR for OD was 12.2 (95% CI 8.26–18.06) and for TD was 7.95 (95% CI 5.48–11.53). TD presented a sensitivity of 41.1% (95% CI 34.4–46.1), a specificity of 91.9% (95% CI 89.8–93.7), a PPV of 56.2% (95% CI48.0–64.2) and a NPV of 86.1% (95% CI 83.6–88.3), while the OD showed a sensitivity of 45.0% (95% CI 37.6–51.5), a specificity of 93.7% (95% CI 91.8–95.0), a PPV of 64.4% (95% CI 56.0–72.1) and a NPV of 87.1% (95% CI 84.7–89.2). CONCLUSIONS: More than half of the subjects with SARS-CoV-2 infection have OD or TD. The presence of OD or TD could be of diagnostic utility due to its ability to predict infection in more than half of the cases.
format Online
Article
Text
id pubmed-8141902
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-81419022021-05-24 Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection() Pérula de Torres, Luis Ángel González-Lama, Jesús Jiménez García, Celia Sánchez Montero, Rosa Rider Garrido, Faustino Ortega López, Yolanda Pajares Conde, Diego Ramírez Baena, Miguel Párraga Martínez, Ignacio Romero-Rodríguez, Esperanza Med Clin (Engl Ed) Original Article BACKGROUND AND OBJECTIVE: Olfactory and taste dysfunction (OD, TD) have been considered symptoms of SARS-CoV-2 infection. However, its presence in certain populations, especially those with mild clinical symptoms, has not been clarified. The objective was to estimate the frequency of OD and TD, and its predictive validity in patients detected in Primary Care. PATIENTS AND METHODS: A cross-sectional study was carried out in the Spanish National Health System. An epidemiological survey was administered to patients who were requested the PCR test for SARS-CoV-2. Odds ratio (OR) were estimated to measure the magnitude of the association between OD and TD and the existence of SARS-CoV-2 infection. The sensitivity, specificity, and positive and negative predictive values (PPV, NPV) of these symptoms in SARS-CoV-2 infection were calculated. RESULTS: Of 1038 patients screened, 20.1% had SARS-CoV-2 infection. OD and DG were present in 64.4% (95% CI 56.0–72.1) and 56.2% (95% CI 47.9–64.2) of the subjects with infection, respectively. The OR for OD was 12.2 (95% CI 8.26–18.06) and for TD was 7.95 (95% CI 5.48–11.53). TD presented a sensitivity of 41.1% (95% CI 34.4–46.1), a specificity of 91.9% (95% CI 89.8–93.7), a PPV of 56.2% (95% CI48.0–64.2) and a NPV of 86.1% (95% CI 83.6–88.3), while the OD showed a sensitivity of 45.0% (95% CI 37.6–51.5), a specificity of 93.7% (95% CI 91.8–95.0), a PPV of 64.4% (95% CI 56.0–72.1) and a NPV of 87.1% (95% CI 84.7–89.2). CONCLUSIONS: More than half of the subjects with SARS-CoV-2 infection have OD or TD. The presence of OD or TD could be of diagnostic utility due to its ability to predict infection in more than half of the cases. Elsevier España, S.L.U. 2021-06-25 2021-05-24 /pmc/articles/PMC8141902/ /pubmed/34056110 http://dx.doi.org/10.1016/j.medcle.2020.12.024 Text en © 2021 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Pérula de Torres, Luis Ángel
González-Lama, Jesús
Jiménez García, Celia
Sánchez Montero, Rosa
Rider Garrido, Faustino
Ortega López, Yolanda
Pajares Conde, Diego
Ramírez Baena, Miguel
Párraga Martínez, Ignacio
Romero-Rodríguez, Esperanza
Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection()
title Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection()
title_full Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection()
title_fullStr Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection()
title_full_unstemmed Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection()
title_short Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection()
title_sort frequency and predictive validity of olfactory and taste dysfunction in patients with sars-cov-2 infection()
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141902/
https://www.ncbi.nlm.nih.gov/pubmed/34056110
http://dx.doi.org/10.1016/j.medcle.2020.12.024
work_keys_str_mv AT peruladetorresluisangel frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT gonzalezlamajesus frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT jimenezgarciacelia frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT sanchezmonterorosa frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT ridergarridofaustino frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT ortegalopezyolanda frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT pajarescondediego frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT ramirezbaenamiguel frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT parragamartinezignacio frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT romerorodriguezesperanza frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection
AT frequencyandpredictivevalidityofolfactoryandtastedysfunctioninpatientswithsarscov2infection